Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Antisense oligonucleotides can reduce androgen receptor levels in skin cells, suggesting potential for treating skin disorders.

Silencing SFRP1 alone promotes hair growth, but adding DKK1 does not help.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Targeting the p300/AR axis may help treat polycystic ovary syndrome.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Male pattern baldness is caused by certain cells in hair follicles and could potentially be treated by targeting a specific growth factor, TGF-β1.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Male hormones can cause hair loss, but treatments like Minoxidil and Finasteride can help, and targeting TGF-B1 could be a future solution.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

Hormones like testosterone affect skin functions and can cause skin issues when in excess; treatments to manage these effects are only somewhat effective.

Androgens promote beard growth but cause hair loss in androgenetic alopecia, with TGF-β1 as a potential treatment target.

Early onset hair loss linked to genetics and androgen levels.

Excess androgens may cause PCOS, not just be a symptom.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Analog 23 is a promising compound for prostate cancer treatment.

A new topical treatment using SAMiRNA technology shows promise in increasing hair growth for androgenetic alopecia.

Inflammation and immunity play a key role in androgenetic alopecia, with better treatment outcomes in certain immune-positive cases.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.